Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | FPR2 | P25090 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30445952 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL2543429 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL934498 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL1863400 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL30052816 | 0.96 | ALDH1A1 (0.56) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL30051944 | 0.93 | ALDH1A1 (0.53) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL29696992 | 0.93 | ALDH1A1 (0.53) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL30051532 | 0.93 | ALDH1A1 (0.53) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL30011402 | 0.90 | ALDH1A1 (0.50) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL8975146 | 0.90 | ALDH1A1 (0.49) | ALDH1A1ENPEPL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | claimed |
| CN-119736362-A | Preparation method and application of spirulina polypeptide | 无限极（中国）有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| US-12097237-B2 | Small molecule Ras inhibitors | OHIO STATE INNOVATION FOUNDATION (US) | 2024-09-24 | — | — | US | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| CN-114395014-B | Ox horn characteristic peptide fragment and detection method thereof | 南京中医药大学 | 2024-02-23 | — | — | CN | claimed |
| CN-116425838-A | Polypeptide compound and medical application thereof | 北京拓界生物医药科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116003529-A | Polypeptide and application thereof in repairing mucous membrane injury or skin injury | 四川好医生攀西药业有限责任公司 | 2023-04-25 | — | — | CN | claimed |
| EP-1957061-B1 | COMBINATION COMPRISING AT LEAST ONE AMINO ACID AND A PKR INHIBITOR FOR USE IN THE TREATMENT OF MUSCLE LOSS | NESTEC SA (CH) | 2011-05-11 | — | — | EP | claimed |
| US-20110028392-A1 | METHODS FOR USE OF BRANCHED AMINO ACIDS | NESTEC S.A. (CH) | 2011-02-03 | — | — | US | claimed |
| US-20090170786-A1 | METHODS FOR THE USE OF BRANCHED CHAIN AMINO ACIDS | NESTEC S.A. (CH) | 2009-07-02 | — | — | US | claimed |
| US-20090105123-A1 | METHODS FOR THE TREATMENT OF MUSCLE LOSS | NESTEC S.A. (CH) | 2009-04-23 | — | — | US | claimed |
| CN-101316582-A | Method of treating muscle loss | NESTEC SA (CH) | 2008-12-03 | — | — | CN | claimed |
| CN-101282657-A | Methods for the use of branched chain amino acids | NESTEC SA (CH) | 2008-10-08 | — | — | CN | claimed |
| EP-1957061-A1 | METHODS FOR THE TREATMENT OF MUSCLE LOSS | NESTEC S.A. (CH) | 2008-08-20 | — | — | EP | claimed |
| EP-1940252-A2 | METHODS FOR THE USE OF BRANCHED CHAIN AMINO ACIDS | NESTEC S.A. (CH) | 2008-07-09 | — | — | EP | claimed |
| WO-2007064618-A1 | METHODS FOR THE TREATMENT OF MUSCLE LOSS | NESTEC S.A. (CH) | 2007-06-07 | — | — | WO | claimed |
| WO-2007053390-A2 | METHODS FOR THE USE OF BRANCHED CHAIN AMINO ACIDS | NESTEC S.A. (CH) | 2007-05-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12097237-B2 | Small molecule Ras inhibitors | KRAS, HRAS, NRAS | ALDH1A1 3074/4885ENPEP 3211/4885L3MBTL1 2732/4885 |
| US-20090105123-A1 | METHODS FOR THE TREATMENT OF MUSCLE LOSS | BCAT2, CPT1B, BCAT1 | ALDH1A1 3467/4885ENPEP 107/4885L3MBTL1 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.